AndersonJ, HeldN, WrightK. Raynaud's phenomenon of the nipple: A treatable cause of painful breastfeeding. Pediatrics, 2004; 113:e360–e364.
2.
Lawlor-SmithL, Lawlor-SmithC. Vasospasm of the nipple—A manifestation of Raynaud's phenomenon: Case reports. BMJ, 1997; 314:644–645.
3.
Avila-VegaJ, Urrea-MendozaE, LeeC. Raynaud's phenomenon of the nipple as a side-effect of labetalol: Case report and literature review. Case Rep Womens Health, 2019; 23:e00135.
4.
WaldmanR, FinchJ, Grant-KelsJ, et al.Reply: Additional clinical pearls for the management of Raynaud phenomenon of the nipple. J Am Acad Dermatol, 2019; 81:e113.
5.
StringerT, FemiaA. Raynaud's phenomenon: Current concepts. Clin Dermatol, 2018; 36:498–507.
6.
ThompsonA, PopeJ. Calcium channel blockers for primary Raynaud's phenomenon: A meta-analysis. Rheumatology (Oxford), 2005; 44:145–150.
7.
RoustitM, BlaiseS, AllanoreY, et al.Phosphodiesterase-5 inhibitors for the treatment of secondary Raynaud's phenomenon: Systematic review and meta-analysis of randomised trials. Ann Rheum Dis, 2013; 72:1696–1699.
8.
QiuO, ChanT, LuenM, et al.Use of nitroglycerin ointment to treat primary and secondary Raynaud's phenomenon: A systematic literature review. Rheumatol Int, 2018; 38:2209–2216.
9.
CurtissP, SchwagerZ, CobosG, et al.A systematic review and meta-analysis of the effects of topical nitrates in the treatment of primary and secondary Raynaud's phenomenon. J Am Acad Dermatol, 2018; 78:1110.e1113–1118.e1113.
10.
O'SullivanS, KeithM. Raynaud phenomenon of the nipple: A rare finding in rheumatology clinic. J Clin Rheumatol, 2011; 17:371–372.
11.
NotiA, GrobK, BiedermannM, et al.Exposure of babies to C(15)-C(45) mineral paraffins from human milk and breast salves. Regul Toxicol Pharmacol, 2003; 38:317–325.
12.
MorinoC, WinnS. Raynaud's phenomenon of the nipples: An elusive diagnosis. J Hum Lact, 2007; 23:191–193.
13.
BelchJ, ShawB, O'DowdA, et al.Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: A double blind study. Thromb Haemost, 1985; 54:490–494.
